Fundz

Cyllene

Paris, Ile-de-France, France · Biotechnology, Health Care, Therapeutics

Cyllene, previously known as EG 427, is a Paris-based biotechnology company focused on developing a genetic medicine platform for neurological diseases using non-replicating HSV-1 vectors. Its lead candidate, EG110A, targets bladder dysfunction in patients with spinal cord injuries. The company aims to achieve focal transduction and selective expression of transgenes in targeted subsets of neurons

Key facts

Headquarters
Paris, Ile-de-France, France
Employees
400
Industries
Biotechnology, Health Care, Therapeutics
Website
groupe-cyllene.com
LinkedIn
Company page

Recent activity at Cyllene

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Cyllene funding history

DateRoundAmount
Jul 2026Series C$37.6M

Companies similar to Cyllene

About Cyllene: questions and answers

What does Cyllene do?

Cyllene, previously known as EG 427, is a Paris-based biotechnology company focused on developing a genetic medicine platform for neurological diseases using non-replicating HSV-1 vectors. Its lead candidate, EG110A, targets bladder dysfunction in patients with spinal cord injuries. The company aims to achieve focal transduction and selective expression of transgenes in targeted subsets of neurons

Where is Cyllene headquartered?

Cyllene is headquartered in Paris, Ile-de-France, France.

How many employees does Cyllene have?

Cyllene has about 400 employees.

Has Cyllene raised funding?

Yes. Fundz has recorded 1 funding event for Cyllene. The most recent, Series C of $37.6M, was in Jul 2026.

What is the latest news on Cyllene?

On Jul 7, 2026, Cyllene, formerly EG 427, has raised €33m in a Series C funding round co-led by GordonMD Global Investments and M Ventures to advance its genetic medicine platform.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Cyllene across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.